Related Experiment Videos
Cefotaxime use in pediatric infections
1Division of Infectious Diseases, Children's Hospital of Michigan, Detroit 48201, USA.
Insights
Cefotaxime is a vital antibiotic for serious pediatric bacterial infections like meningitis and sepsis. Judicious use is crucial due to rising resistance in common pathogens such as pneumococci.
Area of Science:
- Pediatric Infectious Diseases
- Antimicrobial Stewardship
Background:
- Cefotaxime has been a cornerstone in treating serious pediatric bacterial infections, including meningitis and sepsis, for over a decade in the US.
- While effective against many pathogens, the emergence of penicillin- and cephalosporin-resistant pneumococci presents a growing clinical challenge.
- Overuse of cephalosporins has led to increased antimicrobial resistance and resource strain in healthcare settings.
Purpose of the Study:
- To review the established role of cefotaxime in pediatric infectious disease management.
- To highlight the evolving landscape of pediatric bacterial pathogens and resistance patterns.
- To emphasize the importance of antimicrobial stewardship for cephalosporin use in pediatric populations.
Main Methods:
- Review of clinical literature and usage patterns of cefotaxime in pediatric centers.
- Analysis of common pediatric bacterial infections and their causative agents.
- Examination of antimicrobial resistance trends, particularly for Streptococcus pneumoniae.
Main Results:
- Cefotaxime remains a critical therapeutic option for severe pediatric infections, despite reduced Haemophilus influenzae type b incidence.
- Increasing resistance to penicillin and third-generation cephalosporins among pneumococci necessitates careful treatment strategies.
- Widespread and sometimes inappropriate use of cephalosporins has contributed to resistance and increased healthcare costs.
Conclusions:
- Cefotaxime continues to be essential for treating serious pediatric bacterial infections.
- The rise of resistant pneumococci underscores the need for updated treatment guidelines and vigilant monitoring.
- Judicious prescribing of cefotaxime and other cephalosporins is paramount to preserve their efficacy and manage healthcare resources effectively.
Abstract:
Cefotaxime has been used extensively in many pediatric centers in the United States for the past 10 or more years. Its main usage has been for the treatment of various serious bacterial infections in pediatric patients, primarily meningitis and sepsis. It has also been used to treat intraabdominal, urinary tract, soft tissue, bone, and joint infections. Although there has been a marked reduction in the incidence of invasive Haemophilus influenzae type b infections following the introduction of effective vaccines, cefotaxime remains very useful against the other common pathogens causing serious infections in pediatric patients. The increasing number of pneumococci resistant to penicillin and third-generation cephalosporins has created a new challenge for the management of serious pneumococcal infections. In many institutions, cephalosporins in general have been overused and abused, resulting in the emergence of resistant organisms and an increasing burden on resources. The judicious use of cefotaxime and other cephalosporins should be emphasized.